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Abstract
Large, symptomatic and ruptured abdominal aortic aneurysms are usually treated surgically if patients are deemed fit
enough. This may be achieved through endovascular or open surgical repair. The type of treatment that a patient
receives is dependant on many factors, such as the rupture status of the aneurysm. Each approach is also associated with
different risks and postoperative complications. Multiple guidelines exist to inform the surgical management of
abdominal aortic aneurysms. This literature review combines these recommendations and explores the evidence upon
which they are based. In addition, it highlights the key perioperative considerations that need to be considered in cases
of unruptured and ruptured abdominal aortic aneurysms.
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Introduction
An abdominal aortic aneurysm (AAA) is defined as an
irreversible dilatation of the abdominal aorta to a
diameter greater than 3.0 cm or 1.5 times its normal
anteroposterior diameter (NICE 2020). There are many
risk factors that contribute to AAA development,
including age, male sex and smoking status. As a result,
many countries including the United Kingdom (UK) have
developed screening programmes for at-risk groups. In
the UK, AAA screening is offered to men within the year
of their sixty-fifth year birthday (Public Health England
2019). In 2019, this identified AAAs in approximately 1%
of all men screened (Public Health England 2019).
However, not all AAAs are asymptomatic; patients with
an unruptured AAA may experience a persistent
abdominal or lower back pain and a pulsating sensation
in the abdomen, while those with a ruptured abdominal
aortic aneurysm (rAAA) may present with sudden, severe
back pain and shock (NHS 2017). Unfortunately, rAAAs
are the primary presentation for 50% of patients and
have a mean in-hospital mortality rate of 35.4% after
repair (Jeanmonod et al 2020, National Vascular
Registry 2019).
Due to the poor outcomes associated with rAAAs, the
National Institute for Health and Care Excellence (NICE),
European Society for Vascular Surgery (ESVS) and the
Society for Vascular Surgery (SVS) have published
comprehensive guidelines on the surgical management
and surveillance of patients with AAAs (Chaikof et al
2018, NICE 2020, Wanhainen et al 2019). This review
explores these recommendations, highlighting the key
perioperative factors that need to be considered in the
care of these patients.
Decision for surgery
According to NICE, surgical repair should be considered
for unruptured AAAs in patients that are either
symptomatic, asymptomatic with an AAA >4 cm that has
grown >1 cm in one year, or asymptomatic with an AAA
5.5 cm (NICE 2020). Similarly, the ESVS guidelines
recommend surgery for male patients with AAA
diameters of 5.5 cm (Wanhainen et al 2019). In
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comparison, surgery may be considered for female
patients with AAA diameters of 5.0 cm, or between
5 and 5.4 cm (Chaikof et al 2018, Wanhainen et al
2019). The decision to treat must also consider other
factors, such as patient preference and fitness for
surgery (NICE 2020). Currently, the ESVS guidelines do
not recommend elective repair of AAA in those with
limited life expectancy (Wanhainen et al 2019). rAAAs,
however, are a true emergency and require urgent repair
in patients fit for surgery (Chaikof et al 2018). Both
unruptured AAAs and rAAAs can be treated using
endovascular aneurysm repair (EVAR) or open surgical
repair (OSR).
Unruptured AAAs
EVAR. EVAR is a minimally invasive, X-ray-guided
method of AAA repair that involves inserting an
expandable stent (endograft), into the AAA through an
incision in the groin (Figure 1(a)). This patches the
aneurysm and reduces the risk of rupture. While EVAR
does not result in a lower overall mortality in elective AAA
repair, it is associated with decreased operative time,
blood loss, total hospital length of stay and
postoperative pulmonary complications, compared to
OSR (Paravastu et al 2014). As a result, EVAR is now the
most common technique for elective repair in the UK
(Johal et al 2019). It should be noted, however, that
elective EVAR has recently decreased in the UK due to
the publication of the draft NICE guidelines, which
discouraged its use (Loftus et al 2020).
While NICE acknowledges the superiority of EVAR in the
short term, they only recommend EVAR for unruptured
AAAs in patients who meet the aforementioned criteria
and are contraindicated from OSR (NICE 2020).
Reasons for this include a lack of benefit in long-term
survival, more long-term complications and re-
interventions and a lack of cost-effectiveness (NICE
2020). The ESVS makes a more relaxed
recommendation, that EVAR should be used first in
those with suitable anatomy and reasonable life
expectancy (Wanhainen et al 2019). If a patient has low
life expectancy, elective AAA repair is not recommended
(Wanhainen et al 2019).
OSR. During OSR, an abdominal incision is made to
reach the AAA, which is then replaced with a durable
prosthetic graft (Figure 1(b)). OSR involves clamping the
abdominal aorta, which can lead to significantly higher
rates of acute kidney injury (AKI) than EVAR after surgery
(Ambler et al 2015). Advantages of OSR include a lower
rate of long-term complications over a mean follow-up of
12.7 years and fewer re-interventions compared to EVAR
(12% vs. 26%) (Patel et al 2016).
NICE recommends OSR for patients with unruptured
AAAs who meet the above criteria and do not have the
following contraindications: abdominal co-pathology,
high anaesthetic risk and medical comorbidities (NICE
2020). NICE have not precisely defined medical
comorbidities or high-anaesthetic risk, so clinicians have
some degree of flexibility in interpreting this (Loftus et al
2020). The SVS notes that OSR is used in patients who
do not meet the anatomical requirements for EVAR
(Chaikof et al 2018). These include those with severe
aortic angulation, excessive thrombus or even the
presence of numerous accessory renal arteries (Chaikof
et al 2018). The ESVS guidelines, however, recommend
OSR over EVAR in all patients with long life expectancy
(Wanhainen et al 2019).
Mortality rates. While the overall mortality rates are
similar between EVAR and OSR, they differ at various
time points after surgery (Patel et al 2016). Patients
undergoing EVAR have a significantly lower 30-day or in-
hospital mortality rate than OSR patients (1.3% vs.
Figure 1 Surgical repair of AAAs. (a) Cross section of an AAA treated via EVAR. (b) OSR
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4.7%), which continues for the first six months (4% vs.
7%) (Patel et al 2016, Stather et al 2013). This early
advantage is corroborated by more recent data, in which
the in-hospital mortality rate for infra-renal AAAs is
reported as 0.4% after EVAR, compared with 3.2% after
OSR (National Vascular Registry 2019). However,
between six months and four years, there is no
significant difference in mortality between methods
(21% vs. 20%) (Patel et al 2016). In fact, due to the high
rate of long-term complications associated with EVAR,
the mortality rate >8 years post-intervention is
significantly greater compared to OSR (53% vs. 46%)
(Patel et al 2016).
Ruptured AAAs
rAAAs treated with EVAR have been shown to have a
lower in-hospital postoperative mortality rate than OSR
(22.6% vs. 40.9%) (National Vascular Registry 2019).
For the treatment of rAAAs, NICE note that EVAR
provides more benefit than OSR for most people,
especially men over 70 (NICE 2020). The SVS also
advocates the use of EVAR over OSR for rAAAs if it is
anatomically feasible (Chaikof et al 2018). The ESVS
notes that a particular advantage of EVARs in cases of
rAAA is the ability to perform the procedure under local
anaesthesia, which, if used alone, results in a reduced
30-day mortality (Wanhainen et al 2019). Contrastingly,
OSR provides a better balance of benefits and harms in
men under 70 and should also be considered in cases
where standard EVAR is unsuitable (NICE 2020). For
women, NICE recommends EVAR at any age (NICE
2020). In fact, women have been shown to benefit more
from EVAR compared to men (Powell et al 2014).
Ultimately, irrespective of the method chosen, the SVS
recommends a door-to-intervention time of <90 min for
rAAAs (Chaikof et al 2018).
Postoperative considerations
Location of care
The decision to admit patients following AAA repair
should be made on a case-by-case basis, depending on
their stability, risk factors and intraoperative
complications. For example, ICU admission is advisable
in patients who require mechanical ventilation and
those that had haemodynamic instability during surgery
(Chaikof et al 2018). Unnecessary admission occupies
valuable bed space and according to a recent report, an
ICU stay after OSR is associated with higher rates of
atrial fibrillation, pneumonia, kidney injury and five-year
mortality compared to discharge to a vascular surgery
ward (Varetto et al 2019). As such, the SVS recommends
that only patients who have pre-existing cardiac,
pulmonary and/or renal conditions should be routinely
managed in an ICU after surgery (Chaikof et al 2018).
Wherever these patients are ultimately managed,
healthcare teams should remain vigilant for
postoperative complications.
Early complications
Myocardial infarction and other cardiac complications
are a common cause of death in AAA patients (Powell et
al 2017). Cardiac-related deaths occur in 8% of elective
EVAR patients and 7.1% of OSR patients, with no
significant difference between groups (Paravastu et al
2014). Postoperative ST-segment monitoring should
therefore be used in all patients with a high cardiac risk
following EVAR as well as all patients after OSR (Chaikof
et al 2018). Where this identifies ECG changes, or the
patient complains of chest pain, clinicians should order
an urgent troponin (Chaikof et al 2018). If sinus
tachycardia is identified and/or the patient describes
pleuritic chest pain, the differential diagnosis should
include a pulmonary embolism (PE) secondary to venous
thromboembolism (VTE). For this reason, all AAA
patients are assessed for VTE risk and given appropriate
thromboprophylaxis (NICE 2020).
In the elective setting, the rate of renal complications
requiring postoperative dialysis has been reported as
1.5% following EVAR and 1.2% after OSR, with no
statistical difference between methods (Paravastu et al
2014). The 30-day mortality rate in patients who
developed renal failure after elective OSR has been
reported as 35.0%, compared to 4.3% for those without
renal failure (Grant et al 2012). Whereas in patients
treated for rAAAs, AKI occurs more frequently following
OSR (43%) than EVAR (26%) (Ambler et al 2015). The
high rate of AKI after OSR may be attributed to aortic
clamping, with more proximal clamp positions during
anastomosis resulting in an increased risk of severe AKI
(Ambler et al 2015). In comparison, AKI after EVAR is
thought to be due to contrast nephropathy (Lee et al
2017). The SVS recommends that at-risk patients
undergoing EVAR receive hydration with normal saline or
5% dextrose/sodium bicarbonate, both pre and
postoperatively (Chaikof et al 2018).
Abdominal compartment syndrome (ACS) is defined as a
sustained intra-abdominal pressure (IAP) >20 mmHg,
associated with new organ dysfunction (Kirkpatrick et al
2013). In Sweden, ACS occurs in 1% following OSR and
0.2% after EVAR for unruptured AAAs; however, in those
with rAAAs, these figures increased to 3.7% and 7.5%,
respectively (Ersryd et al 2019). The reason ACS more
commonly occurs in cases of rupture is because the
mass effect of bleeding directly increases IAP. This
decreases blood flow to the abdominal organs, causing
intestinal ischaemia, multiple organ failure and an
increased mortality at 30-days after surgery (Ersryd et al
2016, NICE 2020). For these reasons, NICE
recommends that patients are assessed for ACS if their
condition does not improve postoperatively (NICE 2020).
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Decompressive laparotomy is the management of
choice for ACS (Kirkpatrick et al 2013).
Ischaemic complications are also an important cause of
morbidity and mortality following surgical AAA repair,
occurring in 9% of patients in the US (Maldonado et al
2004). Of these patients, 75% had lower extremity
ischaemia and 14% had colonic ischaemia (CI)
(Maldonado et al 2004). CI is associated with especially
poor outcomes; mortality rates up to 73% and re-
intervention rates of 27–54% have been reported after
elective EVAR (Williamson et al 2018). Moreover, EVAR is
also associated with a reduced incidence of CI
compared with OSR (Lee et al 2016, Williamson et al
2018). However, where OSR is performed, surgeons
should preserve blood flow to at least one internal iliac
artery to reduce the risk of colonic ischaemia, as well as
buttock claudication (Wanhainen et al 2019). The ESVS
guidelines emphasize the need to closely monitor all
rAAA patients in the postoperative period for CI
(Wanhainen et al 2019).
Pulmonary complications are significantly more likely
after open repair than EVAR (8.3% vs. 3.1%), and in
males, smokers and elderly patients (Paravastu et al
2014, Pasin et al 2017). Other acute complications
include multi-organ failure, stroke and incisional hernia
(Paravastu et al 2014).
Late complications
Graft infection is a rare but life-threatening complication
of AAA repair. In a large US study, graft infection was
reported in 0.19% of OSR patients and 0.16% of EVAR
patients at two years post-surgery (Vogel et al 2008).
The risk of graft infection is highest in the first year,
although it occurs at a median time of 3.0 years (Vogel
et al 2008). Emergency procedures and re-operations
are particularly associated with graft infections
(Tsapralis et al 2011). High-grade infections may result
in sepsis, pseudoaneurysm, graft thrombosis,
haematemesis due to aortoenteric fistulation and
anastomotic disruption (Treska et al 2016). Overall, the
mortality rate associated with infection is high, ranging
from 37% to 40% depending on the treatment method
(Niaz et al 2020).
To prevent graft infection, patients should receive
antibiotic prophylaxis before high-risk procedures if the
potential for infection exists, or the patient is
immunocompromised (Chaikof et al 2018). Where there
is a clinical suspicion of infection, investigations should
include a computer tomography (CT) scan. If this
identifies extensive contamination with gross purulence,
extra-anastomotic reconstruction should be performed,
followed by excision of all graft material and aortic
stump closure (Chaikof et al 2018). In the absence of
such contamination, in situ reconstruction with a
cryopreserved allograft is preferred (Chaikof et al 2018).
The duration of antibiotic treatment after removal of the
infected graft is controversial, with some authors
recommending life-long treatment and others as little as
six weeks (Treska et al 2016).
An endoleak is defined as the persistence of blood flow
outside an endovascular stent–graft, but within the
aneurysm sac (NICE 2020). There are five main types of
endoleaks to be aware of (Figure 2). The main danger of
endoleaks is secondary rupture of the AAA, which occurs
in 2.4% of EVAR patients at a median time of 3.5 years
and carries a 30-day mortality rate of 62% (Powell et al
2017). Endoleaks and other EVAR complications like
device migration make secondary AAA rupture
significantly more prevalent in EVAR patients than OSR
patients, whom only experience rupture in 0.1% of cases
(Stather et al 2013).
Type II endoleaks are the most common and have an
incidence of 10.2% among EVAR patients (Sidloff et al
2013). Fortunately, 35.4% resolve spontaneously
(Sidloff et al 2013). However, where resolution does not
Figure 2 Types of endoleak. (I) Type I: blood flowing into the AAA because of an incomplete/ineffective seal. (II) Type II: retrograde
blood flow into the AAA from side branches. (III) Type III: blood flowing into the AAA through endograft defects. (IV) Type IV: blood
flowing into the AAA through the stent–graft fabric. (V) Type V: AAA expansion without radiographic evidence of a leak site.
Definitions based on NICE 2020
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occur, a persistent type II endoleak increases the risk of
AAA growth and rupture (Jones et al 2007). Guidelines
therefore recommend surveillance for type II endoleaks
not associated with aneurysm expansion and treatment
of those associated with aneurysm expansion (Chaikof
et al 2018, NICE 2020, Wanhainen et al 2019). One
report suggests that interventions are able to
successfully seal the endoleak in 71.5% of cases, with
translumbar embolization generally producing higher
clinical success rates and lower complication rates than
transarterial embolization (Sidloff et al 2013).
Type I and III endoleaks are associated with elevated sac
pressures and occur in 4.3% and 1.3% of EVAR patients,
respectively, accounting for 54% of aneurysm ruptures
in EVAR patients (Antoniou et al 2015, Chaikof et al
2018, Powell et al 2017). As such, both NICE and the
SVS recommend treatment upon detection using open,
endovascular or percutaneous interventions (Chaikof et
al 2018, NICE 2020, Wanhainen et al 2019).
Interestingly, the majority of proximal type I endoleaks
resolve on their own within a year (O’Donnell et al 2018).
Clinicians may therefore want to reconsider immediate
intervention in these patients. Similarly, type IV
endoleaks often seal spontaneously and so intervention
is not recommended in this group (Chaikof et al 2018,
NICE 2020, Wanhainen et al 2019).
Type V endoleaks (endotension) are rare with newer
grafts and occur in only 0.6% of EVAR patients (Powell et
al 2017). They are thought to arise secondary to other
occult endoleaks, and as the aneurysm diameter
enlarges, can lead to more serious endoleaks including
type I/III. These patients therefore require thorough
investigation (NICE 2020). Treatment should be
individualised and may include observation, re-lining of
low-porosity endografts or explantation, depending on
sac growth (Chaikof et al 2018, Wanhainen et al 2019).
Surveillance
EVAR patients suffer significantly more complications
than OSR patients in the long term; the complication
rate has been reported as 10.7 per 100 person-years in
EVAR patients, compared with 0.8 per 100 person-years
in OSR patients (Powell et al 2017). They are also
significantly more likely to require re-interventions, with
26% of EVAR patients needing re-intervention in a 15-
year follow-up study, compared with only 12% of OSR
patients (Patel et al 2016).
Due to the high incidence of complications in the 5-year
period after EVAR, patients should undergo
postoperative surveillance (Chaikof et al 2018, NICE
2020, Wanhainen et al 2019). The SVS recommends a
contrast-enhanced CT scan (CECT) and a colour duplex
ultrasound scan (DUS) within one month (Chaikof et al
2018). In the absence of endoleak or sac enlargement,
they recommend another scan at 12 months and yearly
follow-up using DUS. If a type II endoleak is found at one
month, another CECT and DUS is required at six months.
If a stable sac size is observed, then a six-monthly DUS
should be carried out for 24 months, followed by yearly
follow-up (Chaikof et al 2018).
The ESVS recommend risk stratification based on CECT
within 30 days postoperatively (Wanhainen et al 2019).
Low-risk patients show no endoleaks, an adequate seal
and require CT imaging every five years. Intermediate-
risk patients have an adequate seal but a type II
endoleak. They require annual follow-up for expansion
with a DUS; if there is sac shrinkage 1 cm, they are
managed as per low-risk patients. If there is expansion
1 cm, patients are managed as high risk. High-risk
patients have an inadequate seal or type I/III endoleak.
These patients should be assessed for re-intervention,
especially in type I/III endoleaks. Patients with an
inadequate seal but no endoleaks need repeat CECT to
accurately assess progression. All patients should be
reimaged every five years (Wanhainen et al 2019).
NICE, on the other hand, recommend that the frequency
of surveillance should be assessed on a case-by-case
basis, depending on each patient’s risk of EVAR-related
complications (NICE 2020). They state that CECT or a
colour DUS should be used to assess AAA diameter and
EVAR device limb kinking, rather than both together.
Where endoleak is suspected, CECT should be used for
diagnosis. Crucially, a colour DUS alone should not be
used due to its suboptimal sensitivity for type I/III
endoleaks and dependency on skill (NICE, 2020).
Following OSR, the SVS recommends an abdominal and
pelvic CT scan every five years to check for aneurysmal
dilatations or anastomotic aneurysms (Chaikof et al
2018). However, NICE do not recommend surveillance
post-OSR due to its relatively low incidence of
complications (NICE 2020).
Conclusion
There are multiple surgical methods of treating AAAs,
each with different risks and outcomes. The type of
operation chosen is therefore complex, and a number of
factors need to be considered. Moreover, healthcare
professionals should remain alert for common
complications that can arise in the postoperative period
and patients should undergo surveillance. An awareness
of these key perioperative factors is required to optimise
the care that these patients receive.
Key phrases
1. AAAs are associated with significant morbidity and
mortality.
2. AAAs can undergo endovascular or open surgical
repair.
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3. The type of surgical repair chosen depends on a vari-
ety of factors.
4. There are many complications that may arise in the
postoperative period.
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